Gsa Capital Partners LLP Amarin Corp Plcuk Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$0.63 - $1.07 $188,132 - $319,526	-298,623 Reduced 20.14%	1,183,917 $815,000
Q1 2024 May 03, 2024	BUY	$0.82 - $1.35 $518,647 - $853,870	632,497 Added 74.41%	1,482,540 $1.32 Million
Q4 2023 Feb 16, 2024	BUY	$0.66 - $0.91 $530,884 - $731,976	804,370 Added 1761.15%	850,043 $739,000
Q3 2023 Nov 15, 2023	SELL	$0.85 - $1.43 $37,987 - $63,908	-44,691 Reduced 49.46%	45,673 $42,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.49 $91,336 - $121,509	-81,550 Reduced 47.44%	90,364 $107,000
Q1 2023 May 12, 2023	BUY	$1.19 - $2.19 $204,577 - $376,491	171,914 New	171,914 $257,000
Q3 2021 Nov 12, 2021	SELL	$3.94 - $5.84 $200,230 - $296,788	-50,820 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$4.26 - $6.5 $216,493 - $330,330	50,820 New	50,820 $223,000
Q4 2020 Feb 03, 2021	SELL	$4.04 - $5.31 $100,890 - $132,606	-24,973 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$3.64 - $7.76 $90,901 - $193,790	24,973 New	24,973 $105,000
Q3 2019 Nov 12, 2019	SELL	$13.89 - $23.16 $213,003 - $355,158	-15,335 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$16.27 - $20.51 $301,857 - $380,522	-18,553 Reduced 54.75%	15,335 $297,000
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $48,460 - $85,814	-3,843 Reduced 10.19%	33,888 $704,000
Q4 2018 Feb 12, 2019	SELL	$12.41 - $22.98 $1.78 Million - $3.3 Million	-143,769 Reduced 79.21%	37,731 $514,000
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $45,815 - $304,249	18,700 Added 11.49%	181,500 $2.95 Million
Q2 2018 Aug 09, 2018	BUY	$2.68 - $3.48 $173,932 - $225,852	64,900 Added 66.29%	162,800 $503,000
Q1 2018 May 11, 2018	SELL	$2.99 - $4.44 $208,403 - $309,468	-69,700 Reduced 41.59%	97,900 $295,000
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $226,134 - $302,251	73,900 Added 78.87%	167,600 $672,000
Q3 2017 Nov 20, 2017	BUY	$3.03 - $3.72 $283,911 - $348,564	93,700	93,700 $328,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$10.9 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$5.46 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.46 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.12 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.1 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account